MA42667A - Compositions et systèmes multiplexés pour la transcription-traduction et la synthèse protéique couplées sans cellules et procédés pour les utiliser - Google Patents
Compositions et systèmes multiplexés pour la transcription-traduction et la synthèse protéique couplées sans cellules et procédés pour les utiliserInfo
- Publication number
- MA42667A MA42667A MA042667A MA42667A MA42667A MA 42667 A MA42667 A MA 42667A MA 042667 A MA042667 A MA 042667A MA 42667 A MA42667 A MA 42667A MA 42667 A MA42667 A MA 42667A
- Authority
- MA
- Morocco
- Prior art keywords
- multiplex
- translation
- compositions
- cell
- systems
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/50—Biochemical production, i.e. in a transformed host cell
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562207844P | 2015-08-20 | 2015-08-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA42667A true MA42667A (fr) | 2021-05-05 |
Family
ID=58051779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA042667A MA42667A (fr) | 2015-08-20 | 2016-08-19 | Compositions et systèmes multiplexés pour la transcription-traduction et la synthèse protéique couplées sans cellules et procédés pour les utiliser |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20180237847A1 (fr) |
| EP (1) | EP3337490A4 (fr) |
| CA (1) | CA2994304A1 (fr) |
| MA (1) | MA42667A (fr) |
| WO (1) | WO2017031399A1 (fr) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3430153A1 (fr) * | 2016-04-14 | 2019-01-23 | DSM Sinochem Pharmaceuticals Netherlands B.V. | Protéines type mbth dans des processus eucaryotes catalysés par nrps |
| IL308091B1 (en) | 2016-09-13 | 2026-01-01 | Allergan Inc | Protein-free stabilized Clostridium toxin preparations |
| US20190376069A1 (en) * | 2017-02-07 | 2019-12-12 | The Regents Of The University Of California | Use of microbial consortia in the production of multi-protein complexes |
| CN108374028B (zh) * | 2017-02-27 | 2021-05-11 | 扬州大学 | 一种利用化学表观遗传修饰提高海洋真菌中azaphilone类化合物产量的方法 |
| US20200109429A1 (en) * | 2017-03-06 | 2020-04-09 | Synvitrobio, Inc. | Methods and Systems for Cell-Free Biodiscovery of Natural Products |
| CN106978471A (zh) * | 2017-03-27 | 2017-07-25 | 海南大学 | 一种酰基转移酶标记的工程化噬菌体快速检测微生物 |
| US20210108191A1 (en) * | 2017-04-04 | 2021-04-15 | The Board Of Trustees Of The University Of Illinois | Methods of Production of Biologically Active Lasso Peptides |
| KR101969506B1 (ko) * | 2017-05-04 | 2019-08-13 | 주식회사 앤코스메슈 | 곰보버섯 추출물을 유효성분으로 포함하며 항암효능을 갖는 혼합 조성물 |
| CN109321620A (zh) * | 2017-07-31 | 2019-02-12 | 康码(上海)生物科技有限公司 | 一种蛋白合成冻干制剂及其制备方法和应用 |
| CN107602609B (zh) * | 2017-08-31 | 2020-07-21 | 湖南理工学院 | 一种以p(o)-oh化合物与含甲基取代芳香烃制备有机磷酸酯类化合物的方法 |
| US20230193337A1 (en) * | 2017-10-19 | 2023-06-22 | Synvitrobio, Inc. | Anaerobic Cell-Free Systems and Environments and Methods for Making and Using Same |
| CN112739345A (zh) | 2017-11-06 | 2021-04-30 | 斯奈普生物公司 | Pim激酶抑制剂组合物,方法和其用途 |
| GB2584211B (en) * | 2017-11-16 | 2023-05-24 | Synthex Inc | Selective modulation of protein-protein interactions |
| WO2019127469A1 (fr) * | 2017-12-29 | 2019-07-04 | 康码(上海)生物科技有限公司 | Système énergétique de régénération à haut rendement (ser), kit et sa méthode de préparation |
| CN108192908A (zh) * | 2018-01-29 | 2018-06-22 | 天津大学 | 利用筑波链霉菌提高他克莫司发酵产量的方法 |
| CN108504669A (zh) * | 2018-03-21 | 2018-09-07 | 天津大学 | 一种含小分子糖的体外高效合成蛋白质的系统 |
| EP3774847A4 (fr) * | 2018-03-30 | 2022-04-20 | Lassogen, Inc. | Procédés de production, de découverte et d'optimisation de peptides lasso |
| WO2019195655A1 (fr) * | 2018-04-06 | 2019-10-10 | University Of Florida Research Foundation, Incorporated | Souches de streptomyces albus modifiées |
| US12173343B2 (en) * | 2018-06-06 | 2024-12-24 | Syngulon Sa | Engineering antimicrobial peptides |
| GB201817971D0 (en) | 2018-11-02 | 2018-12-19 | British American Tobacco Investments Ltd | Method |
| US10768173B1 (en) | 2019-09-06 | 2020-09-08 | Element Biosciences, Inc. | Multivalent binding composition for nucleic acid analysis |
| US12325884B2 (en) | 2019-03-04 | 2025-06-10 | Northwestern University | Riboswitch-based fluoride sensing in cell-free extract |
| CN111778222B (zh) * | 2019-04-04 | 2024-03-22 | 中国科学院微生物研究所 | 一个能在真菌中产生黄酮类化合物的nrps-pks杂合蛋白及其编码基因与应用 |
| CN109988219B (zh) * | 2019-04-22 | 2020-06-05 | 云南大学 | 一种倍半萜环己烯酮类化合物及其制备方法和应用 |
| CN110343639B (zh) * | 2019-07-23 | 2021-04-27 | 中国医药集团总公司四川抗菌素工业研究所 | 一株产15(s)-o-乙基雷帕霉素的链霉菌 |
| CN214973877U (zh) | 2019-08-09 | 2021-12-03 | 胡桃钳医疗公司 | 用于形成治疗性多核苷酸的微流体设备及微流体路径装置 |
| US11287422B2 (en) | 2019-09-23 | 2022-03-29 | Element Biosciences, Inc. | Multivalent binding composition for nucleic acid analysis |
| CN110643578B (zh) * | 2019-10-25 | 2021-02-19 | 浙江工商大学 | 一株抗阿维拉霉素a单克隆抗体杂交瘤细胞株及其应用 |
| CN110863002A (zh) * | 2019-11-29 | 2020-03-06 | 武汉赛维尔生物科技有限公司 | 一种改造次级翻译起始位点使蛋白正确表达的方法 |
| CA3166826A1 (fr) * | 2020-01-06 | 2021-07-15 | Lassogen, Inc. | Peptides lassos pour le traitement du cancer |
| WO2021174199A1 (fr) * | 2020-02-28 | 2021-09-02 | Synvitrobio, Inc. | Procédés et compositions pour identifier des caractères à l'aide d'un système acellulaire |
| CN113717909B (zh) * | 2020-05-26 | 2024-11-05 | 杭州中美华东制药有限公司 | 一种达托霉素高产菌株及其应用 |
| CN113046380A (zh) * | 2021-03-19 | 2021-06-29 | 清华大学 | 一种基于σ因子作为转录元件的无细胞蛋白质合成方法 |
| CN115612718A (zh) * | 2021-07-13 | 2023-01-17 | 中国科学院北京基因组研究所(国家生物信息中心) | 一种单细胞翻译组测序的方法 |
| EP4573213A1 (fr) | 2022-08-15 | 2025-06-25 | Element Biosciences, Inc. | Capture sur surface à résolution spatiale d'acides nucléiques |
| WO2025037122A1 (fr) | 2023-08-16 | 2025-02-20 | Nuclera Ltd | Réactifs d'expression protéique |
| CN118834893A (zh) * | 2024-08-26 | 2024-10-25 | 广东工业大学 | 基于艰难梭菌的无细胞基因表达体系 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5480772A (en) * | 1993-02-03 | 1996-01-02 | Brandeis University | In vitro activation of a nucleus |
| US6495348B1 (en) * | 1993-10-07 | 2002-12-17 | Regents Of The University Of Minnesota | Mitomycin biosynthetic gene cluster |
| US20020142397A1 (en) * | 2000-12-22 | 2002-10-03 | Philippe Collas | Methods for altering cell fate |
| AU2009245445B2 (en) * | 2008-05-09 | 2013-09-26 | Regenics As | Cellular extracts |
| US20130316397A1 (en) * | 2012-04-30 | 2013-11-28 | The Board Of Trustees Of The Leland Standford Junior University | Cell-Free Polypeptide Synthesis |
-
2016
- 2016-08-19 MA MA042667A patent/MA42667A/fr unknown
- 2016-08-19 EP EP16837891.7A patent/EP3337490A4/fr not_active Withdrawn
- 2016-08-19 WO PCT/US2016/047704 patent/WO2017031399A1/fr not_active Ceased
- 2016-08-19 CA CA2994304A patent/CA2994304A1/fr active Pending
- 2016-08-19 US US15/752,884 patent/US20180237847A1/en not_active Abandoned
-
2023
- 2023-03-13 US US18/120,951 patent/US20230399688A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3337490A4 (fr) | 2019-07-24 |
| CA2994304A1 (fr) | 2017-02-23 |
| US20180237847A1 (en) | 2018-08-23 |
| US20230399688A1 (en) | 2023-12-14 |
| WO2017031399A1 (fr) | 2017-02-23 |
| EP3337490A1 (fr) | 2018-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA42667A (fr) | Compositions et systèmes multiplexés pour la transcription-traduction et la synthèse protéique couplées sans cellules et procédés pour les utiliser | |
| IL272367A (en) | Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies | |
| IL291604A (en) | Stabilized soluble pre-fusion rsv f proteins | |
| IL269209A (en) | Replacement of cytotoxic preconditioning before cellular immunotherapy | |
| EP3302706A4 (fr) | Compositions et procédés pour la dégradation de protéines mal pliées | |
| LT3563250T (lt) | Technologijos, skirtos saugiai išplėsti debesijos paslaugų api debesijos paslaugų rinkoje | |
| DK3307322T3 (da) | Humaniserede anti-cd40-antistoffer og anvendelser deraf | |
| EP3589662A4 (fr) | Protéine monovalente inductible de fixation d' antigène | |
| IL259713A (en) | Anti-dr5 antibodies and methods of use thereof | |
| DK3303395T3 (da) | Anti-cd40-antistoffer og anvendelser deraf | |
| DK3541841T3 (da) | Anti-PD-1-antistoffer og sammensætninger | |
| IL263223A (en) | Antibodies against cd40 and their uses | |
| EP3503901A4 (fr) | Procédés et compositions pour cellules de moelle épinière | |
| DK3273992T3 (da) | Antistoffer mod ICOS | |
| DK3368572T3 (da) | Anti-pd-1-antistoffer og -sammensætninger | |
| EP3155018A4 (fr) | Protéines de fusion à anticorps à région constante et compositions les contenant | |
| DK3316909T3 (da) | Anti-ntb-a-antistoffer og relaterede sammensætninger og fremgangsmåder | |
| EP3268050A4 (fr) | Compositions de conjugués de protéines porogènes et procédés correspondants | |
| CU20150117A7 (es) | Inmunoterapia tau | |
| EP3548073A4 (fr) | Protéines de fusion pour l'appauvrissant sélective d'anticorps spécifiques d'un antigène | |
| EP3350197A4 (fr) | Procédés et systèmes de synthèse de peptide en phase solide | |
| EP3529280A4 (fr) | Anticorps dirigés contre les protéines mica et micb | |
| EP2910076A4 (fr) | Systèmes et procédés pour une synchronisation efficace de canaux | |
| EP3256163A4 (fr) | Méthodes et compositions pour moduler les protéines lilr | |
| EP3288587A4 (fr) | Modulation de réponse immunitaire au moyen d'anticorps agonistes de btla |